NASDAQ RESUMED AT 09:53 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:53 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:52 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:47 AM
NASDAQ RESUMED AT 09:47 AM
NASDAQ RESUMED AT 09:30 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:30 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Biopharma dealmaking on way to record year, says HSBC
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: GSK Announces Tender Offer To Acquire Nuvalent
Factbox: Major deals involving US drugmakers and biotechs over the past decade
AbbVie sharpens immunology focus with $10.9 billion Apogee deal (updated)
AbbVie strikes $10.9 billion deal for Apogee Therapeutics
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal (updated)